We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Tag: heart failure
MedXY News
EnglishTag

heart failure

Ask MedXY AI
type 2 diabetesclinical trialheart failureimmunotherapyobesitycardiovascular riskatrial fibrillationbiomarkerscritical careclinical trialsHypertensionartificial intelligenceCardiologyoncologypublic healthtype 1 diabetesdiabetesMortalityAlzheimer's diseasecardiovascular diseasebreast cancerepidemiology

Latest news

Tag

Bridging Evidence-Based and Personalized Medicine in Heart Failure and Cardiomyopathies: Balancing Standardization with Individualization
CardiologyY học dựa trên bằng chứngheart failure

Bridging Evidence-Based and Personalized Medicine in Heart Failure and Cardiomyopathies: Balancing Standardization with Individualization

By MedXY|Sep 17, 2026

This article explores the integration of evidence-based medicine and personalized approaches in managing heart failure and inherited cardiomyopathies, proposing a framework to optimize patient care by harmonizing standardized guidelines wit

Cardiac Resynchronization Therapy: Metabolomic Insights into Heart Failure Improvement
Cardiologyleft ventricular ejection fraction
Cardiac Resynchronization Therapy

Cardiac Resynchronization Therapy: Metabolomic Insights into Heart Failure Improvement

By MedXY|Sep 15, 2026

This study reveals how cardiac resynchronization therapy (CRT) improves left ventricular function in heart failure patients and modulates systemic metabolomic profiles, highlighting differences between ischemic and nonischemic cardiomyopath

Heart Failure in Portuguese Adults Aged 50 and Above: Insights from the PORTHOS Study on Prevalence and Predominant Phenotypes
CardiologyHFpEFepidemiology

Heart Failure in Portuguese Adults Aged 50 and Above: Insights from the PORTHOS Study on Prevalence and Predominant Phenotypes

By MedXY|Sep 15, 2026

The PORTHOS study reveals a 16.5% prevalence of heart failure among Portuguese adults aged 50+, with HFpEF constituting over 90% of cases, mostly undiagnosed, highlighting the need for enhanced screening strategies in aging populations.

Genetic Insights into Early Heart Failure Risk in Hypoplastic Left Heart Syndrome: Findings from the NC-DEFINE Study
Cardiologycardiomyopathygenetic screening

Genetic Insights into Early Heart Failure Risk in Hypoplastic Left Heart Syndrome: Findings from the NC-DEFINE Study

By MedXY|Sep 12, 2026

A prospective study reveals that ultra-rare cardiomyopathy gene variants significantly increase risk for early heart failure in infants with hypoplastic left heart syndrome, highlighting potential for genetic risk stratification and precisi

Advancing Prognostic Precision in HFpEF: The LIFE-Preserved Risk Prediction Model
CardiologyHFpEFheart failure

Advancing Prognostic Precision in HFpEF: The LIFE-Preserved Risk Prediction Model

By MedXY|Sep 11, 2026

The LIFE-Preserved model accurately predicts short-term and lifetime risks of heart failure hospitalization or cardiovascular death in HFpEF patients, enabling tailored clinical risk stratification and improved management.

Targeting the CXCL9/CXCL10-CXCR3+ CD8+ T Cell Axis: Unraveling Anti-PD-1 Antibody-Associated Cardiotoxicity in Pressure Overload Heart Failure
CardiologyCD8+ T cellsheart failure

Targeting the CXCL9/CXCL10-CXCR3+ CD8+ T Cell Axis: Unraveling Anti-PD-1 Antibody-Associated Cardiotoxicity in Pressure Overload Heart Failure

By MedXY|Sep 6, 2026

Anti-PD-1 antibody exacerbates pressure overload-induced heart failure by promoting CXCR3+ CD8+ T cell infiltration, which impairs cardiomyocyte mitochondrial function via granzyme B and perforin. This study identifies a novel immunopathoge

Enhancing Heart Failure Care: Impact of Get With The Guidelines-Heart Failure Hospital Participation on Medical Therapy and Patient Outcomes
Cardiologyheart failureGet With The Guidelines

Enhancing Heart Failure Care: Impact of Get With The Guidelines-Heart Failure Hospital Participation on Medical Therapy and Patient Outcomes

By MedXY|Sep 5, 2026

Participation in the GWTG-HF program modestly improves guideline-directed medical therapy intensity and reduces short- and long-term mortality in patients hospitalized for heart failure with reduced ejection fraction.

Impact of Cold Spells, Heat Waves, and Ambient Temperature Variations on Heart Failure Hospitalization Risk: Insights from Sweden and Beyond
Cardiologyheart failurehospitalization risk

Impact of Cold Spells, Heat Waves, and Ambient Temperature Variations on Heart Failure Hospitalization Risk: Insights from Sweden and Beyond

By MedXY|Sep 5, 2026

This review synthesizes evidence linking short-term exposure to cold and heat extremes with increased heart failure hospitalizations, highlighting mechanistic biomarker studies and telemonitoring findings that elucidate temperature-driven H

Consistent Efficacy of Vutrisiran in Transthyretin Cardiac Amyloidosis Amidst Concomitant Disease-Modifying Therapies
CardiologyDisease-Modifying TherapyHELIOS-B trial

Consistent Efficacy of Vutrisiran in Transthyretin Cardiac Amyloidosis Amidst Concomitant Disease-Modifying Therapies

By MedXY|Sep 3, 2026

The HELIOS-B trial demonstrates that vutrisiran significantly reduces mortality and cardiovascular events in ATTR-CM patients, with its efficacy unaffected by concurrent use of tafamidis or heart failure medications, supporting its broad th

Improving Heart Failure Outcomes in India: Evidence from the TIME-HF Nurse-Coordinated, Digital-Supported Care Model Trial
Cardiologyheart failuredigital health

Improving Heart Failure Outcomes in India: Evidence from the TIME-HF Nurse-Coordinated, Digital-Supported Care Model Trial

By MedXY|Sep 1, 2026

A nurse-led, mobile health-supported collaborative care intervention significantly increased days alive and out of hospital and reduced mortality among Indian patients with heart failure with reduced ejection fraction over 2 years.

Low-Normal Hemoglobin Concentrations and Clinical Outcomes in Heart Failure: Rethinking WHO Anemia Thresholds
Clinical Updatesanemiaclinical outcomes

Low-Normal Hemoglobin Concentrations and Clinical Outcomes in Heart Failure: Rethinking WHO Anemia Thresholds

By MedXY|Aug 29, 2026

This review synthesizes current evidence on hemoglobin thresholds in heart failure, highlighting that optimal prognosis is associated with hemoglobin levels higher than WHO anemia cutoffs, with clinical implications for management and iron

Sex-Specific Skeletal Muscle Inflammation and Dysfunction in Heart Failure with Reduced Ejection Fraction
CardiologyMacrophagesskeletal muscle inflammation

Sex-Specific Skeletal Muscle Inflammation and Dysfunction in Heart Failure with Reduced Ejection Fraction

By MedXY|Aug 28, 2026

This study reveals distinct sex differences in skeletal muscle inflammation and dysfunction in patients with HFrEF, highlighting divergent immune cell profiles linked to muscle mass and strength variations in men versus women, advancing und

Optimizing Heart Failure with Reduced Ejection Fraction Management: Insights from Swedish Registry on Quadruple Therapy Adherence and Persistence
Cardiologyheart failurepharmacotherapy adherence

Optimizing Heart Failure with Reduced Ejection Fraction Management: Insights from Swedish Registry on Quadruple Therapy Adherence and Persistence

By MedXY|Aug 27, 2026

A Swedish cohort study reveals increased adoption and high adherence to quadruple pharmacotherapy in HFrEF, associating treatment persistence with better clinical outcomes and highlighting areas for improved dosing and continuation.

Evaluating the Specificity of Capillary Leak Indices in Heart Failure: Implications for Clinical Practice
Cardiologyheart failurecapillary leak indices

Evaluating the Specificity of Capillary Leak Indices in Heart Failure: Implications for Clinical Practice

By MedXY|Aug 26, 2026

This study demonstrates the lack of mechanistic specificity of clinical capillary leak indices in heart failure patients, underscoring their limitations as universal markers of endothelial permeability beyond acute inflammatory states.

The Second Universal Definition of Heart Failure (2026): What Clinicians and Health Systems Need to Know
Cardiologyheart failureuniversal definition

The Second Universal Definition of Heart Failure (2026): What Clinicians and Health Systems Need to Know

By MedXY|Aug 25, 2026

A clear, global update standardizing heart failure terminology, phenotypes, causes, and trajectories to improve prevention, diagnosis, treatment, and global surveillance.

Advancements in Heart Failure Management: Insights from the JROADHF and JROADHF-NEXT Registries
CardiologyPhục hồi chức năng timGuideline therapy

Advancements in Heart Failure Management: Insights from the JROADHF and JROADHF-NEXT Registries

By MedXY|Aug 22, 2026

This article reviews improvements in heart failure management and outcomes in Japan between 2013 and 2019-21, highlighting increased guideline-based therapy use and enhanced post-discharge care leading to reduced mortality and readmission r

Unmasking Silent Heart Failure in Diabetes: Insights from the TARTAN-HF Trial
CardiologydiabetesHFpEF

Unmasking Silent Heart Failure in Diabetes: Insights from the TARTAN-HF Trial

By MedXY|Aug 21, 2026

The TARTAN-HF trial demonstrated that targeted natriuretic peptide screening in high-risk diabetic patients uncovers a high prevalence of undiagnosed heart failure, mainly HFpEF, enabling earlier treatment initiation and improved clinical c

Personalized Risk Modeling of Interatrial Shunt Therapy in Heart Failure: Insights from the RELIEVE-HF Trial
CardiologyHFpEFinteratrial shunt

Personalized Risk Modeling of Interatrial Shunt Therapy in Heart Failure: Insights from the RELIEVE-HF Trial

By MedXY|Aug 15, 2026

The RELIEVE-HF trial reveals distinct predictors of outcomes after interatrial shunt implantation in HFrEF and HFpEF, enabling personalized risk modeling to identify patients likely to benefit from this therapy.

Unveiling Heart Failure Risks in Newly Diagnosed Diabetes: The Critical Role of Insulin Resistance and Renal Function
Cardiologyepidemiologydiabetes

Unveiling Heart Failure Risks in Newly Diagnosed Diabetes: The Critical Role of Insulin Resistance and Renal Function

By MedXY|Aug 13, 2026

This study reveals a high heart failure risk within 5 years of diabetes diagnosis, highlighting insulin resistance and reduced kidney function as independent predictors beyond conventional risk factors.

Efficacy and Safety of Mineralocorticoid Receptor Antagonists Across Racial Groups in Heart Failure: Insights From a Large-Scale Individual Participant Data Meta-Analysis
CardiologyClinical Trial Meta-AnalysisRace

Efficacy and Safety of Mineralocorticoid Receptor Antagonists Across Racial Groups in Heart Failure: Insights From a Large-Scale Individual Participant Data Meta-Analysis

By MedXY|Aug 8, 2026

This meta-analysis of four placebo-controlled trials reveals no significant difference in the efficacy and safety of mineralocorticoid receptor antagonists between Black and non-Black patients with heart failure, regardless of heart failure

1 / 9
123…9
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure
Intimate Health
What Makes a Woman "Physiologically Addicted" Is Never Money, But These Two Relationship Qualities